Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001385508-21-000116
Filing Date
2021-08-20
Accepted
2021-08-20 16:04:42
Documents
1
Period of Report
2021-08-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_162948986846434.html 4  
1 FORM 4 wf-form4_162948986846434.xml 4 4417
  Complete submission text file 0001385508-21-000116.txt   6075
Mailing Address 233 WILSHIRE BLVD, SUITE 280 SUITE 500 SANTA MONICA CA 90401
Business Address 233 WILSHIRE BLVD, SUITE 280 SUITE 500 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Issuer) CIK: 0001385508 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O OPIANT PHARMACEUTICALS, INC. 401 WILSHIRE BOULEVARD, 12TH FLOOR SANTA MONICA CA 90401
Business Address
Thomas Thomas T. (Reporting) CIK: 0001689819 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38193 | Film No.: 211193848